United Therapeutics Corporation Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount
United Therapeutics Corporation (UTHR) reported Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount of -$1.20 million for the 12-month period ending 2024-12-31, per its 10-K filed 2025-02-26.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherReconcilingItems · last filed 2025-02-26
- United Therapeutics Corporation effective income tax rate reconciliation, other reconciling items, amount for fiscal 2024 was -$1.20M.
- United Therapeutics Corporation effective income tax rate reconciliation, other reconciling items, amount for fiscal 2023 was $0.00.
- United Therapeutics Corporation effective income tax rate reconciliation, other reconciling items, amount for fiscal 2022 was -$3.50M, a 294.44% decline from fiscal 2021.
- United Therapeutics Corporation effective income tax rate reconciliation, other reconciling items, amount for fiscal 2021 was $1.80M.
| Period end | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount 12 month | Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount 12 month as first filed |
|---|---|---|
| 2024-12-31 | -$1.20M 10-K · filed 2025-02-26 | |
| 2023-12-31 | $0.00 10-K · filed 2025-02-26 | |
| 2022-12-31 | -$3.50M 10-K · filed 2025-02-26 | |
| 2021-12-31 | $1.80M 10-K · filed 2024-02-21 | $1.00M 10-K · filed 2022-02-24 |
| 2020-12-31 | -$4.90M 10-K · filed 2023-02-22 | -$4.10M 10-K · filed 2021-02-24 |
| 2019-12-31 | -$1.60M 10-K · filed 2022-02-24 | |
| 2018-12-31 | $600.00K 10-K · filed 2021-02-24 | $300.00K 10-K · filed 2019-02-27 |
| 2017-12-31 | $1.30M 10-K · filed 2020-02-26 | |
| 2016-12-31 | $1.10M 10-K · filed 2019-02-27 | |
| 2015-12-31 | -$2.00M 10-K · filed 2018-02-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |